The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Biochemical and imaging markers in patients with thalassaemia.

TitleBiochemical and imaging markers in patients with thalassaemia.
Publication TypeJournal Article
Year of Publication2020
AuthorsVlachou, M., Kamperidis V., Giannakoulas G., Karamitsos T., Vlachaki E., & Karvounis H.
JournalHellenic J Cardiol
Date Published2020 May 06
ISSN2241-5955
Abstract

Beta-thalassaemia is a genetic disease with different clinical aspects, which can lead to heart failure with a multifactorial mechanism. Over the last years, growing interest has been reported for biomarkers that may help in the diagnosis, staging and prognosis of heart disease at an early stage, in patients with beta-thalassaemia. This review will highlight the current clinical value of cardiac biomarkers in patients with beta-thalassaemia and the ongoing research for a possible expanded future use.

DOI10.1016/j.hjc.2020.04.012
Alternate JournalHellenic J Cardiol
PubMed ID32387594

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.